June 19, 2018 4:01 AM ET

Biotechnology

Company Overview of Rani Therapeutics, LLC

Company Overview

Rani Therapeutics, LLC develops oral biotherapeutics technologies for the oral delivery of large drug molecules that include peptides, proteins, and antibodies. It offers TNFa Inhibitors that are used for treatment of inflammatory disorders, including rheumatoid arthritis and Crohn's disease; Parathyroid Hormone for the treatment of osteoporosis; Human Growth Hormone, a peptide hormone that stimulates growth, cell reproduction, and regeneration, as well as is used in the treatment of growth disorders and growth deficiency; and Somatostatin, a growth hormone-inhibiting hormone that is used to treat various indications, including enteroendocrine tumors (in the stomach, intestine, or pancreas),...

2051 Ringwood Avenue

San Jose, CA 95131

United States

Founded in 2012

Phone:

408-457-3712

Key Executives for Rani Therapeutics, LLC

Chairman and Chief Executive Officer
Vice President of Operations
Vice President of Business Development
Vice President of Research & Development
Compensation as of Fiscal Year 2017.

Rani Therapeutics, LLC Key Developments

Dennis Ausiello Joins Board Of Directors For Rani Therapeutics

Rani Therapeutics announced that Dennis (Denny) Ausiello, M.D. has joined its Board of Directors. Dr. Ausiello is a nationally recognized leader in academic medicine, elected to the National Academy of Medicine in 1999 and the American Academy of Arts and Sciences in 2003. He previously served as Chief of Medicine at Massachusetts General Hospital from 1996 until 2013. In this role, he led one of the strongest departments of medicine in the country. Currently the Director of the Center for Assessment Technology and Continuous Health (CATCH), Dr. Ausiello founded this program as a joint effort between Massachusetts General Hospital and Massachusetts Institute of Technology (MIT) physicians, scientists and engineers to provide real-time measurement and analysis of the human phenotype in wellness and disease.

Rani Therapeutics Appoints Dr. Rodolphe Ruffy as First Medical Director

Rani Therapeutics announced that Rodolphe Ruffy, M.D. has joined the company as medical director. Dr. Ruffy brings decades of experience as a practicing physician, including more than 20 years in American academic medicine. In his new role, Dr. Ruffy will be responsible for the company's scientific outreach strategy, including leading the creation and publishing of scientific papers and establishing a Scientific Advisory Board for Rani. Previously, Dr. Ruffy held tenured Professor of Medicine positions at Washington University and the University of Utah.

Shire plc and Rani Therapeutics, LLC Enter into Collaboration to Evaluate Use of the Rani Pill Technology for the Oral Delivery of Factor Therapy

Shire plc and Rani Therapeutics announced a collaboration to exclusively conduct research on the use of the Rani Pill(TM) technology for the oral delivery of factor VIII (FVIII) therapy for patients with hemophilia A. The collaboration agreement grants Shire an exclusive option to negotiate a license to develop and commercialize the technology for delivery of FVIII therapy following completion of feasibility studies. As part of the collaboration, Shire has also made an equity investment into Rani Therapeutics. Rani Therapeutics has developed a novel approach for the oral delivery of large molecules, including peptides, proteins, and antibodies, using the Rani Pill, a capsule that delivers an intestinal injection without exposing medication to digestive enzymes. Once the capsule is consumed, it stays protected until it enters the small intestine and delivers medication into the intestinal wall. Since the intestines do not have sharp pain receptors, the intestinal delivery is expected to be pain free.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 5, 2017
--
Private Placement
August 24, 2017
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rani Therapeutics, LLC, please visit www.ranitherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.